Global Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Flu Vaccine market size was valued at USD 5664.4 million in 2023 and is forecast to a readjusted size of USD 7756.9 million by 2030 with a CAGR of 4.6% during review period.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
The Global Info Research report includes an overview of the development of the Flu Vaccine industry chain, the market status of For Children (6 months to 3 years) (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), For Adults and Children over 3 years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Flu Vaccine.
Regionally, the report analyzes the Flu Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Flu Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Flu Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Flu Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Doses), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Flu Vaccine market.
Regional Analysis: The report involves examining the Flu Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Flu Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Flu Vaccine:
Company Analysis: Report covers individual Flu Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Flu Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (For Children (6 months to 3 years), For Adults and Children over 3 years).
Technology Analysis: Report covers specific technologies relevant to Flu Vaccine. It assesses the current state, advancements, and potential future developments in Flu Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Flu Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Flu Vaccine, with price, sales, revenue and global market share of Flu Vaccine from 2019 to 2024.
Chapter 3, the Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Flu Vaccine.
Chapter 14 and 15, to describe Flu Vaccine sales channel, distributors, customers, research findings and conclusion.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
The Global Info Research report includes an overview of the development of the Flu Vaccine industry chain, the market status of For Children (6 months to 3 years) (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), For Adults and Children over 3 years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Flu Vaccine.
Regionally, the report analyzes the Flu Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Flu Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Flu Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Flu Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Doses), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Flu Vaccine market.
Regional Analysis: The report involves examining the Flu Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Flu Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Flu Vaccine:
Company Analysis: Report covers individual Flu Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Flu Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (For Children (6 months to 3 years), For Adults and Children over 3 years).
Technology Analysis: Report covers specific technologies relevant to Flu Vaccine. It assesses the current state, advancements, and potential future developments in Flu Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Flu Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
- Sanofi Pasteur
- CSL
- GSK
- Mylan
- Hulan Bio
- AstraZeneca
- CCBIO
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Flu Vaccine, with price, sales, revenue and global market share of Flu Vaccine from 2019 to 2024.
Chapter 3, the Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Flu Vaccine.
Chapter 14 and 15, to describe Flu Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Flu Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Flu Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Trivalent Influenza Vaccine
1.3.3 Quadrivalent Influenza Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Flu Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 For Children (6 months to 3 years)
1.4.3 For Adults and Children over 3 years
1.5 Global Flu Vaccine Market Size & Forecast
1.5.1 Global Flu Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Flu Vaccine Sales Quantity (2019-2030)
1.5.3 Global Flu Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Flu Vaccine Product and Services
2.1.4 Sanofi Pasteur Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Flu Vaccine Product and Services
2.2.4 CSL Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CSL Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Flu Vaccine Product and Services
2.3.4 GSK Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GSK Recent Developments/Updates
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Flu Vaccine Product and Services
2.4.4 Mylan Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Mylan Recent Developments/Updates
2.5 Hulan Bio
2.5.1 Hulan Bio Details
2.5.2 Hulan Bio Major Business
2.5.3 Hulan Bio Flu Vaccine Product and Services
2.5.4 Hulan Bio Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Hulan Bio Recent Developments/Updates
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Flu Vaccine Product and Services
2.6.4 AstraZeneca Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AstraZeneca Recent Developments/Updates
2.7 CCBIO
2.7.1 CCBIO Details
2.7.2 CCBIO Major Business
2.7.3 CCBIO Flu Vaccine Product and Services
2.7.4 CCBIO Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 CCBIO Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: FLU VACCINE BY MANUFACTURER
3.1 Global Flu Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Flu Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Flu Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Flu Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Flu Vaccine Manufacturer Market Share in 2023
3.5 Flu Vaccine Market: Overall Company Footprint Analysis
3.5.1 Flu Vaccine Market: Region Footprint
3.5.2 Flu Vaccine Market: Company Product Type Footprint
3.5.3 Flu Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Flu Vaccine Market Size by Region
4.1.1 Global Flu Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Flu Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Flu Vaccine Average Price by Region (2019-2030)
4.2 North America Flu Vaccine Consumption Value (2019-2030)
4.3 Europe Flu Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Flu Vaccine Consumption Value (2019-2030)
4.5 South America Flu Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Flu Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Flu Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Flu Vaccine Consumption Value by Type (2019-2030)
5.3 Global Flu Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Flu Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Flu Vaccine Consumption Value by Application (2019-2030)
6.3 Global Flu Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Flu Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Flu Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Flu Vaccine Market Size by Country
7.3.1 North America Flu Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Flu Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Flu Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Flu Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Flu Vaccine Market Size by Country
8.3.1 Europe Flu Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Flu Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Flu Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Flu Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Flu Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Flu Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Flu Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Flu Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Flu Vaccine Market Size by Country
10.3.1 South America Flu Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Flu Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Flu Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Flu Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Flu Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Flu Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Flu Vaccine Market Drivers
12.2 Flu Vaccine Market Restraints
12.3 Flu Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Flu Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Flu Vaccine
13.3 Flu Vaccine Production Process
13.4 Flu Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Flu Vaccine Typical Distributors
14.3 Flu Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Flu Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Flu Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Trivalent Influenza Vaccine
1.3.3 Quadrivalent Influenza Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Flu Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 For Children (6 months to 3 years)
1.4.3 For Adults and Children over 3 years
1.5 Global Flu Vaccine Market Size & Forecast
1.5.1 Global Flu Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Flu Vaccine Sales Quantity (2019-2030)
1.5.3 Global Flu Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Flu Vaccine Product and Services
2.1.4 Sanofi Pasteur Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Flu Vaccine Product and Services
2.2.4 CSL Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CSL Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Flu Vaccine Product and Services
2.3.4 GSK Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GSK Recent Developments/Updates
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Flu Vaccine Product and Services
2.4.4 Mylan Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Mylan Recent Developments/Updates
2.5 Hulan Bio
2.5.1 Hulan Bio Details
2.5.2 Hulan Bio Major Business
2.5.3 Hulan Bio Flu Vaccine Product and Services
2.5.4 Hulan Bio Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Hulan Bio Recent Developments/Updates
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Flu Vaccine Product and Services
2.6.4 AstraZeneca Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AstraZeneca Recent Developments/Updates
2.7 CCBIO
2.7.1 CCBIO Details
2.7.2 CCBIO Major Business
2.7.3 CCBIO Flu Vaccine Product and Services
2.7.4 CCBIO Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 CCBIO Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: FLU VACCINE BY MANUFACTURER
3.1 Global Flu Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Flu Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Flu Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Flu Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Flu Vaccine Manufacturer Market Share in 2023
3.5 Flu Vaccine Market: Overall Company Footprint Analysis
3.5.1 Flu Vaccine Market: Region Footprint
3.5.2 Flu Vaccine Market: Company Product Type Footprint
3.5.3 Flu Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Flu Vaccine Market Size by Region
4.1.1 Global Flu Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Flu Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Flu Vaccine Average Price by Region (2019-2030)
4.2 North America Flu Vaccine Consumption Value (2019-2030)
4.3 Europe Flu Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Flu Vaccine Consumption Value (2019-2030)
4.5 South America Flu Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Flu Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Flu Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Flu Vaccine Consumption Value by Type (2019-2030)
5.3 Global Flu Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Flu Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Flu Vaccine Consumption Value by Application (2019-2030)
6.3 Global Flu Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Flu Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Flu Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Flu Vaccine Market Size by Country
7.3.1 North America Flu Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Flu Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Flu Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Flu Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Flu Vaccine Market Size by Country
8.3.1 Europe Flu Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Flu Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Flu Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Flu Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Flu Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Flu Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Flu Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Flu Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Flu Vaccine Market Size by Country
10.3.1 South America Flu Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Flu Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Flu Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Flu Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Flu Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Flu Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Flu Vaccine Market Drivers
12.2 Flu Vaccine Market Restraints
12.3 Flu Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Flu Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Flu Vaccine
13.3 Flu Vaccine Production Process
13.4 Flu Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Flu Vaccine Typical Distributors
14.3 Flu Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Flu Vaccine Product and Services
Table 6. Sanofi Pasteur Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Flu Vaccine Product and Services
Table 11. CSL Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. CSL Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Flu Vaccine Product and Services
Table 16. GSK Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. GSK Recent Developments/Updates
Table 18. Mylan Basic Information, Manufacturing Base and Competitors
Table 19. Mylan Major Business
Table 20. Mylan Flu Vaccine Product and Services
Table 21. Mylan Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Mylan Recent Developments/Updates
Table 23. Hulan Bio Basic Information, Manufacturing Base and Competitors
Table 24. Hulan Bio Major Business
Table 25. Hulan Bio Flu Vaccine Product and Services
Table 26. Hulan Bio Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Hulan Bio Recent Developments/Updates
Table 28. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 29. AstraZeneca Major Business
Table 30. AstraZeneca Flu Vaccine Product and Services
Table 31. AstraZeneca Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. AstraZeneca Recent Developments/Updates
Table 33. CCBIO Basic Information, Manufacturing Base and Competitors
Table 34. CCBIO Major Business
Table 35. CCBIO Flu Vaccine Product and Services
Table 36. CCBIO Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. CCBIO Recent Developments/Updates
Table 38. Global Flu Vaccine Sales Quantity by Manufacturer (2019-2024) & (M Doses)
Table 39. Global Flu Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global Flu Vaccine Average Price by Manufacturer (2019-2024) & (US$/Dose)
Table 41. Market Position of Manufacturers in Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 42. Head Office and Flu Vaccine Production Site of Key Manufacturer
Table 43. Flu Vaccine Market: Company Product Type Footprint
Table 44. Flu Vaccine Market: Company Product Application Footprint
Table 45. Flu Vaccine New Market Entrants and Barriers to Market Entry
Table 46. Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Flu Vaccine Sales Quantity by Region (2019-2024) & (M Doses)
Table 48. Global Flu Vaccine Sales Quantity by Region (2025-2030) & (M Doses)
Table 49. Global Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 50. Global Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 51. Global Flu Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 52. Global Flu Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 53. Global Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 54. Global Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 55. Global Flu Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Global Flu Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Global Flu Vaccine Average Price by Type (2019-2024) & (US$/Dose)
Table 58. Global Flu Vaccine Average Price by Type (2025-2030) & (US$/Dose)
Table 59. Global Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 60. Global Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 61. Global Flu Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Global Flu Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Global Flu Vaccine Average Price by Application (2019-2024) & (US$/Dose)
Table 64. Global Flu Vaccine Average Price by Application (2025-2030) & (US$/Dose)
Table 65. North America Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 66. North America Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 67. North America Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 68. North America Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 69. North America Flu Vaccine Sales Quantity by Country (2019-2024) & (M Doses)
Table 70. North America Flu Vaccine Sales Quantity by Country (2025-2030) & (M Doses)
Table 71. North America Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 72. North America Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Europe Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 74. Europe Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 75. Europe Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 76. Europe Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 77. Europe Flu Vaccine Sales Quantity by Country (2019-2024) & (M Doses)
Table 78. Europe Flu Vaccine Sales Quantity by Country (2025-2030) & (M Doses)
Table 79. Europe Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 82. Asia-Pacific Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 83. Asia-Pacific Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 84. Asia-Pacific Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 85. Asia-Pacific Flu Vaccine Sales Quantity by Region (2019-2024) & (M Doses)
Table 86. Asia-Pacific Flu Vaccine Sales Quantity by Region (2025-2030) & (M Doses)
Table 87. Asia-Pacific Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 88. Asia-Pacific Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 89. South America Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 90. South America Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 91. South America Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 92. South America Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 93. South America Flu Vaccine Sales Quantity by Country (2019-2024) & (M Doses)
Table 94. South America Flu Vaccine Sales Quantity by Country (2025-2030) & (M Doses)
Table 95. South America Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 98. Middle East & Africa Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 99. Middle East & Africa Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 100. Middle East & Africa Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 101. Middle East & Africa Flu Vaccine Sales Quantity by Region (2019-2024) & (M Doses)
Table 102. Middle East & Africa Flu Vaccine Sales Quantity by Region (2025-2030) & (M Doses)
Table 103. Middle East & Africa Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Middle East & Africa Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 105. Flu Vaccine Raw Material
Table 106. Key Manufacturers of Flu Vaccine Raw Materials
Table 107. Flu Vaccine Typical Distributors
Table 108. Flu Vaccine Typical Customers
Table 1. Global Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Flu Vaccine Product and Services
Table 6. Sanofi Pasteur Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Flu Vaccine Product and Services
Table 11. CSL Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. CSL Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Flu Vaccine Product and Services
Table 16. GSK Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. GSK Recent Developments/Updates
Table 18. Mylan Basic Information, Manufacturing Base and Competitors
Table 19. Mylan Major Business
Table 20. Mylan Flu Vaccine Product and Services
Table 21. Mylan Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Mylan Recent Developments/Updates
Table 23. Hulan Bio Basic Information, Manufacturing Base and Competitors
Table 24. Hulan Bio Major Business
Table 25. Hulan Bio Flu Vaccine Product and Services
Table 26. Hulan Bio Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Hulan Bio Recent Developments/Updates
Table 28. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 29. AstraZeneca Major Business
Table 30. AstraZeneca Flu Vaccine Product and Services
Table 31. AstraZeneca Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. AstraZeneca Recent Developments/Updates
Table 33. CCBIO Basic Information, Manufacturing Base and Competitors
Table 34. CCBIO Major Business
Table 35. CCBIO Flu Vaccine Product and Services
Table 36. CCBIO Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. CCBIO Recent Developments/Updates
Table 38. Global Flu Vaccine Sales Quantity by Manufacturer (2019-2024) & (M Doses)
Table 39. Global Flu Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global Flu Vaccine Average Price by Manufacturer (2019-2024) & (US$/Dose)
Table 41. Market Position of Manufacturers in Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 42. Head Office and Flu Vaccine Production Site of Key Manufacturer
Table 43. Flu Vaccine Market: Company Product Type Footprint
Table 44. Flu Vaccine Market: Company Product Application Footprint
Table 45. Flu Vaccine New Market Entrants and Barriers to Market Entry
Table 46. Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Flu Vaccine Sales Quantity by Region (2019-2024) & (M Doses)
Table 48. Global Flu Vaccine Sales Quantity by Region (2025-2030) & (M Doses)
Table 49. Global Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 50. Global Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 51. Global Flu Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 52. Global Flu Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 53. Global Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 54. Global Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 55. Global Flu Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Global Flu Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Global Flu Vaccine Average Price by Type (2019-2024) & (US$/Dose)
Table 58. Global Flu Vaccine Average Price by Type (2025-2030) & (US$/Dose)
Table 59. Global Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 60. Global Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 61. Global Flu Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Global Flu Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Global Flu Vaccine Average Price by Application (2019-2024) & (US$/Dose)
Table 64. Global Flu Vaccine Average Price by Application (2025-2030) & (US$/Dose)
Table 65. North America Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 66. North America Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 67. North America Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 68. North America Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 69. North America Flu Vaccine Sales Quantity by Country (2019-2024) & (M Doses)
Table 70. North America Flu Vaccine Sales Quantity by Country (2025-2030) & (M Doses)
Table 71. North America Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 72. North America Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Europe Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 74. Europe Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 75. Europe Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 76. Europe Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 77. Europe Flu Vaccine Sales Quantity by Country (2019-2024) & (M Doses)
Table 78. Europe Flu Vaccine Sales Quantity by Country (2025-2030) & (M Doses)
Table 79. Europe Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 82. Asia-Pacific Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 83. Asia-Pacific Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 84. Asia-Pacific Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 85. Asia-Pacific Flu Vaccine Sales Quantity by Region (2019-2024) & (M Doses)
Table 86. Asia-Pacific Flu Vaccine Sales Quantity by Region (2025-2030) & (M Doses)
Table 87. Asia-Pacific Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 88. Asia-Pacific Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 89. South America Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 90. South America Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 91. South America Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 92. South America Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 93. South America Flu Vaccine Sales Quantity by Country (2019-2024) & (M Doses)
Table 94. South America Flu Vaccine Sales Quantity by Country (2025-2030) & (M Doses)
Table 95. South America Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 98. Middle East & Africa Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 99. Middle East & Africa Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 100. Middle East & Africa Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 101. Middle East & Africa Flu Vaccine Sales Quantity by Region (2019-2024) & (M Doses)
Table 102. Middle East & Africa Flu Vaccine Sales Quantity by Region (2025-2030) & (M Doses)
Table 103. Middle East & Africa Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Middle East & Africa Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 105. Flu Vaccine Raw Material
Table 106. Key Manufacturers of Flu Vaccine Raw Materials
Table 107. Flu Vaccine Typical Distributors
Table 108. Flu Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Flu Vaccine Picture
Figure 2. Global Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Flu Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Trivalent Influenza Vaccine Examples
Figure 5. Quadrivalent Influenza Vaccine Examples
Figure 6. Global Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Flu Vaccine Consumption Value Market Share by Application in 2023
Figure 8. For Children (6 months to 3 years) Examples
Figure 9. For Adults and Children over 3 years Examples
Figure 10. Global Flu Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Flu Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Flu Vaccine Sales Quantity (2019-2030) & (M Doses)
Figure 13. Global Flu Vaccine Average Price (2019-2030) & (US$/Dose)
Figure 14. Global Flu Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Flu Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Flu Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Flu Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Flu Vaccine Average Price by Type (2019-2030) & (US$/Dose)
Figure 29. Global Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Flu Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Flu Vaccine Average Price by Application (2019-2030) & (US$/Dose)
Figure 32. North America Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 52. China Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Flu Vaccine Market Drivers
Figure 73. Flu Vaccine Market Restraints
Figure 74. Flu Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Flu Vaccine in 2023
Figure 77. Manufacturing Process Analysis of Flu Vaccine
Figure 78. Flu Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Flu Vaccine Picture
Figure 2. Global Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Flu Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Trivalent Influenza Vaccine Examples
Figure 5. Quadrivalent Influenza Vaccine Examples
Figure 6. Global Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Flu Vaccine Consumption Value Market Share by Application in 2023
Figure 8. For Children (6 months to 3 years) Examples
Figure 9. For Adults and Children over 3 years Examples
Figure 10. Global Flu Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Flu Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Flu Vaccine Sales Quantity (2019-2030) & (M Doses)
Figure 13. Global Flu Vaccine Average Price (2019-2030) & (US$/Dose)
Figure 14. Global Flu Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Flu Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Flu Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Flu Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Flu Vaccine Average Price by Type (2019-2030) & (US$/Dose)
Figure 29. Global Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Flu Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Flu Vaccine Average Price by Application (2019-2030) & (US$/Dose)
Figure 32. North America Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 52. China Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Flu Vaccine Market Drivers
Figure 73. Flu Vaccine Market Restraints
Figure 74. Flu Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Flu Vaccine in 2023
Figure 77. Manufacturing Process Analysis of Flu Vaccine
Figure 78. Flu Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
